Matches in Wikidata for { <http://www.wikidata.org/entity/Q56700735> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q56700735 description "article scientifique publié en 2003" @default.
- Q56700735 description "article" @default.
- Q56700735 description "im Dezember 2003 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56700735 description "wetenschappelijk artikel" @default.
- Q56700735 description "наукова стаття, опублікована в грудні 2003" @default.
- Q56700735 description "ലേഖനം" @default.
- Q56700735 name "Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease" @default.
- Q56700735 name "Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease" @default.
- Q56700735 type Item @default.
- Q56700735 label "Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease" @default.
- Q56700735 label "Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease" @default.
- Q56700735 prefLabel "Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease" @default.
- Q56700735 prefLabel "Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease" @default.
- Q56700735 P1433 Q56700735-52A37793-A965-4FDD-9ACA-C6CDE6118278 @default.
- Q56700735 P1476 Q56700735-A6D03645-75D2-4119-BE82-0B0486D2F0FD @default.
- Q56700735 P2093 Q56700735-23357FEE-CB90-422B-BC8B-1B78A8E4914B @default.
- Q56700735 P304 Q56700735-292B1549-6E54-4453-9A62-3EA4EC0F0693 @default.
- Q56700735 P31 Q56700735-EEF38A54-8653-43A1-89AB-D935AE10EF4E @default.
- Q56700735 P356 Q56700735-111C2E3B-B840-423B-8F06-1BB0E860E697 @default.
- Q56700735 P407 Q56700735-B9D00268-EC99-4230-9F66-BD4EF330B96B @default.
- Q56700735 P433 Q56700735-DCA7C278-F7BA-4B18-BDD4-0850D59D0A59 @default.
- Q56700735 P478 Q56700735-47B17CBF-FBED-4AD3-BEEA-3614697EBBD1 @default.
- Q56700735 P577 Q56700735-641275DB-C7FA-4B69-8922-5BD811C94FB1 @default.
- Q56700735 P921 Q56700735-4BA4876D-0DE4-45FD-BBC0-3C422D0EDF47 @default.
- Q56700735 P356 01.WNL.0000095219.22086.31 @default.
- Q56700735 P1433 Q1161692 @default.
- Q56700735 P1476 "Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson's disease" @default.
- Q56700735 P2093 "H. Kase" @default.
- Q56700735 P304 "S97-S100" @default.
- Q56700735 P31 Q13442814 @default.
- Q56700735 P356 "10.1212/01.WNL.0000095219.22086.31" @default.
- Q56700735 P407 Q1860 @default.
- Q56700735 P433 "Issue 11, Supplement 6" @default.
- Q56700735 P478 "61" @default.
- Q56700735 P577 "2003-12-08T00:00:00Z" @default.
- Q56700735 P921 Q11085 @default.